0

Back to ROS1 Pathology Testing and Reporting to Inform Targeted Therapy and Treatment
ROS1 Pathology Testing and Reporting to Inform Targeted Therapy and Treatment

ROS1 Pathology Testing and Reporting to Inform Targeted Therapy and Treatment

This online course will feature a 4-faculty, moderated panel discussion of ROS1 rearrangements using problem-based pathology cases in an instructional tumor-board format, emphasizing the multidisciplinary nature of pathology reporting and diagnosis as it affects targeted therapies and patient treatment.

 

The activity offers 1.5 CME, CMLE, or SAMs CME credit.

  • List Price: Free
Item Details:

Awareness of the ROS1 rearrangement biomarkers among the laboratory team must increase to optimize the opportunity for appropriate patients to receive ROS1 testing and targeted therapy. In addition, consistent testing and reporting of ROS1 rearrangement in laboratory reports will provide more...

Back to ROS1 Pathology Testing and Reporting to Inform Targeted Therapy and Treatment
View More View Less

Bought This Bought That ...